This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Ajax Therapeutics, Inc., Schrodinger, LLC. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Innovations of Nicholas Boyles
Introduction
Nicholas Boyles is a notable inventor based in Hillsboro, OR (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit JAK2, a key player in various diseases.
Latest Patents
Nicholas holds three patents, with his latest innovations focusing on 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors. These compounds and their compositions are designed to effectively inhibit JAK2, showcasing his commitment to advancing medical science.
Career Highlights
Nicholas is currently associated with Ajax Therapeutics, Inc., where he applies his expertise in drug development. His work has the potential to impact the treatment of diseases linked to JAK2, highlighting his role in the pharmaceutical industry.
Collaborations
He collaborates with talented individuals such as Craig E Masse and Jeremy Robert Greenwood, contributing to a dynamic research environment that fosters innovation.
Conclusion
Nicholas Boyles exemplifies the spirit of innovation in the pharmaceutical sector, with his patents paving the way for new therapeutic options. His work continues to inspire advancements in medical research and drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile